MR-141 Met Primary And All Secondary Endpoints, Demonstrating Rapid And Sustained Improvement In Near Visual Acuity Without Compromising Distance Vision Safety Profile Consistent With Previous Clinical Trials And No Treatment-Related Serious Adverse Events Reported In […]
PITTSBURGH, May 7, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS) today announced that on May 5, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of […]
PITTSBURGH, Feb. 27, 2025 /PRNewswire/ — Meets 2024 Guidance for Total Revenues, Adjusted […]
PITTSBURGH, Sept. 17, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today the early tender results of the previously announced cash tender offer (the “Maximum Tender Offer”) of its subsidiary Utah […]
PITTSBURGH, Sept. 10, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today that the previously announced cash tender offers (the “Any and All Tender Offers” and each, an “Any and All […]
